Literature references that cite this PDB file's
key reference
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Vincke,
R.Loris,
D.Saerens,
S.Martinez-Rodriguez,
S.Muyldermans,
and
K.Conrath
(2009).
General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold.
|
| |
J Biol Chem, 284,
3273-3284.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Arbabi-Ghahroudi,
R.To,
N.Gaudette,
T.Hirama,
W.Ding,
R.MacKenzie,
and
J.Tanha
(2009).
Aggregation-resistant VHs selected by in vitro evolution tend to have disulfide-bonded loops and acidic isoelectric points.
|
| |
Protein Eng Des Sel, 22,
59-66.
|
 |
|
|
|
|
 |
N.Wang,
W.F.Smith,
B.R.Miller,
D.Aivazian,
A.A.Lugovskoy,
M.E.Reff,
S.M.Glaser,
L.J.Croner,
and
S.J.Demarest
(2009).
Conserved amino acid networks involved in antibody variable domain interactions.
|
| |
Proteins, 76,
99.
|
 |
|
|
|
|
 |
D.P.Simmons,
V.A.Streltsov,
O.Dolezal,
P.J.Hudson,
A.M.Coley,
M.Foley,
D.F.Proll,
and
S.D.Nuttall
(2008).
Shark IgNAR antibody mimotopes target a murine immunoglobulin through extended CDR3 loop structures.
|
| |
Proteins, 71,
119-130.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.A.Barthelemy,
H.Raab,
B.A.Appleton,
C.J.Bond,
P.Wu,
C.Wiesmann,
and
S.S.Sidhu
(2008).
Comprehensive Analysis of the Factors Contributing to the Stability and Solubility of Autonomous Human VH Domains.
|
| |
J Biol Chem, 283,
3639-3654.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
V.Tereshko,
S.Uysal,
A.Koide,
K.Margalef,
S.Koide,
and
A.A.Kossiakoff
(2008).
Toward chaperone-assisted crystallography: protein engineering enhancement of crystal packing and X-ray phasing capabilities of a camelid single-domain antibody (VHH) scaffold.
|
| |
Protein Sci, 17,
1175-1187.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Koide,
R.N.Gilbreth,
K.Esaki,
V.Tereshko,
and
S.Koide
(2007).
High-affinity single-domain binding proteins with a binary-code interface.
|
| |
Proc Natl Acad Sci U S A, 104,
6632-6637.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.A.Olson,
and
R.W.Roberts
(2007).
Design, expression, and stability of a diverse protein library based on the human fibronectin type III domain.
|
| |
Protein Sci, 16,
476-484.
|
 |
|
|
|
|
 |
E.De Genst,
K.Silence,
M.A.Ghahroudi,
K.Decanniere,
R.Loris,
J.Kinne,
L.Wyns,
and
S.Muyldermans
(2005).
Strong in vivo maturation compensates for structurally restricted H3 loops in antibody repertoires.
|
| |
J Biol Chem, 280,
14114-14121.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Revets,
P.De Baetselier,
and
S.Muyldermans
(2005).
Nanobodies as novel agents for cancer therapy.
|
| |
Expert Opin Biol Ther, 5,
111-124.
|
 |
|
|
|
|
 |
M.Arbabi-Ghahroudi,
J.Tanha,
and
R.MacKenzie
(2005).
Prokaryotic expression of antibodies.
|
| |
Cancer Metastasis Rev, 24,
501-519.
|
 |
|
|
|
|
 |
V.Joosten,
R.J.Gouka,
C.A.van den Hondel,
C.T.Verrips,
and
B.C.Lokman
(2005).
Expression and production of llama variable heavy-chain antibody fragments (V(HH)s) by Aspergillus awamori.
|
| |
Appl Microbiol Biotechnol, 66,
384-392.
|
 |
|
|
|
|
 |
E.Veiga,
V.de Lorenzo,
and
L.A.Fernández
(2004).
Structural tolerance of bacterial autotransporters for folded passenger protein domains.
|
| |
Mol Microbiol, 52,
1069-1080.
|
 |
|
|
|
|
 |
R.L.Stanfield,
H.Dooley,
M.F.Flajnik,
and
I.A.Wilson
(2004).
Crystal structure of a shark single-domain antibody V region in complex with lysozyme.
|
| |
Science, 305,
1770-1773.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Lah,
I.Marianovsky,
G.Glaser,
H.Engelberg-Kulka,
J.Kinne,
L.Wyns,
and
R.Loris
(2003).
Recognition of the intrinsically flexible addiction antidote MazE by a dromedary single domain antibody fragment. Structure, thermodynamics of binding, stability, and influence on interactions with DNA.
|
| |
J Biol Chem, 278,
14101-14111.
|
 |
|
|
|
|
 |
M.K.Fenwick,
and
F.A.Escobedo
(2003).
Hybrid Monte Carlo with multidimensional replica exchanges: conformational equilibria of the hypervariable regions of a llama VHH antibody domain.
|
| |
Biopolymers, 68,
160-177.
|
 |
|
|
|
|
 |
R.J.Olsen,
J.Mazlo,
S.A.Koepsell,
T.W.McKeithan,
and
S.H.Hinrichs
(2003).
Minimal structural elements of an inhibitory anti-ATF1/CREB single-chain antibody fragment (scFv41.4).
|
| |
Hybrid Hybridomics, 22,
65-77.
|
 |
|
|
|
|
 |
R.Loris,
I.Marianovsky,
J.Lah,
T.Laeremans,
H.Engelberg-Kulka,
G.Glaser,
S.Muyldermans,
and
L.Wyns
(2003).
Crystal structure of the intrinsically flexible addiction antidote MazE.
|
| |
J Biol Chem, 278,
28252-28257.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Desmyter,
S.Spinelli,
F.Payan,
M.Lauwereys,
L.Wyns,
S.Muyldermans,
and
C.Cambillau
(2002).
Three camelid VHH domains in complex with porcine pancreatic alpha-amylase. Inhibition and versatility of binding topology.
|
| |
J Biol Chem, 277,
23645-23650.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.M.Pérez,
J.G.Renisio,
J.J.Prompers,
C.J.van Platerink,
C.Cambillau,
H.Darbon,
and
L.G.Frenken
(2001).
Thermal unfolding of a llama antibody fragment: a two-state reversible process.
|
| |
Biochemistry, 40,
74-83.
|
 |
|
|
|
|
 |
A.Skerra
(2000).
Engineered protein scaffolds for molecular recognition.
|
| |
J Mol Recognit, 13,
167-187.
|
 |
|
|
|
|
 |
J.Maynard,
and
G.Georgiou
(2000).
Antibody engineering.
|
| |
Annu Rev Biomed Eng, 2,
339-376.
|
 |
|
|
|
|
 |
S.Spinelli,
L.G.Frenken,
P.Hermans,
T.Verrips,
K.Brown,
M.Tegoni,
and
C.Cambillau
(2000).
Camelid heavy-chain variable domains provide efficient combining sites to haptens.
|
| |
Biochemistry, 39,
1217-1222.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
V.K.Nguyen,
R.Hamers,
L.Wyns,
and
S.Muyldermans
(2000).
Camel heavy-chain antibodies: diverse germline V(H)H and specific mechanisms enlarge the antigen-binding repertoire.
|
| |
EMBO J, 19,
921-930.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|